About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $4.21 | Open | |
| Volume | Market Cap | 55.43M | |
| Yield | Last Dividend |
| Anixa Biosciences to Present at the B. R... | 01/13/21 |
| SAN JOSE, Calif., Jan. 13, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Worldwide Industry for CAR-T Cell Therap... | 01/07/21 |
| DUBLIN , Jan. 7, 2021 /PRNewswire/ -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials and Trends, 2021" report has been added t... | |
| Anixa Biosciences to Present at the H.C.... | 01/05/21 |
| SAN JOSE, Calif., Jan. 5, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention... | |
| Anixa Biosciences Covid-19 Therapy Demon... | 12/14/20 |
| SAN JOSE, Calif., Dec. 14, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Analyzing The Price Action In Anixa Bios... | 12/10/20 |
| Anixa Biosciences???s Stock Price And Volume Action Anixa Biosciences???s (NASDAQ: ANIX) stock has been rising Thursday, up 77.85% to a price of ??? | |
| Anixa Biosciences to Host Conference Cal... | 10/27/20 |
| SAN JOSE, Calif., Oct. 27, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| 51 Biggest Movers From Yesterday | 10/02/20 |
| Gainers Solid Biosciences Inc. (NASDAQ: SLDB ) shares climbed 70.4% to close at $3.46 on Thursday after the company announced the FDA has lifted the c... | |
| Anixa Biosciences to Present at the 2020... | 09/08/20 |
| SAN JOSE, Calif., Sept. 8, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preventio... | |
| Anixa nabs European patent covering CAR-... | 07/10/20 |
| Thinly traded nano cap Anixa Biosciences (NASDAQ:ANIX) jumps 11% premarket on increased volume in reaction to its announcement that it has received an... | |
| Anixa Biosciences' CAR-T Cancer Therapy ... | 07/10/20 |
| SAN JOSE, Calif. , July 10, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX ), a biotechnology company focused on the treatment and prevent... | |
| Anixa and OntoChem complete initial scre... | 07/06/20 |
| Anixa Biosciences (ANIX -6.3%) along with its partner, OntoChem has completed the initial in silico screening process of their drug discovery program ... | |
| Anixa Announces Strategic Program Realig... | 07/02/20 |
| SAN JOSE, Calif., July 2, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention... | |
| ViewRay and NantKwest among healthcare g... | 06/30/20 |
| Gainers: Calliditas Therapeutics (NASDAQ:CALT) +20%. ViewRay (NASDAQ:VRAY) +19%. Anixa Biosciences (NASDAQ:ANIX) +19%. OptiNose (NASDAQ:OPTN) +18%. Na... | |
| Anixa Biosciences Announces Publication ... | 04/23/20 |
| SAN JOSE, Calif., April 23, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention,... | |
| Anixa Biosciences and OntoChem Announce ... | 04/20/20 |
| SAN JOSE, Calif., April 20, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention,... | |
| Anixa Biosciences Announces Presentation... | 01/06/20 |
| SAN JOSE, Calif., Jan. 6, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune... | |
| Anixa Biosciences to Present at Biotech ... | 12/23/19 |
| SAN JOSE, Calif., Dec. 23, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immun... | |
| Anixa Biosciences Announces Genesis Rese... | 11/26/19 |
| SAN JOSE, Calif., Nov. 26, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immun... | |
| The Daily Biotech Pulse: Roche-Spark Dea... | 11/22/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 21.... | |
| Anixa Biosciences Announces Collaboratio... | 11/20/19 |
| SAN JOSE, Calif. , Nov. 20, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX ), a biotechnology company focused on harnessing the body's imm... | |
| Anixa Biosciences Names Novartis Executi... | 10/28/19 |
| SAN JOSE, Calif., Oct. 28, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immun... | |
| Daily Insider Ratings Round Up 4/26/19 | 04/29/19 |
| No summary available. | |
| Daily Insider Ratings Round Up 4/24/19 | 04/26/19 |
| No summary available. | |
| Daily Insider Ratings Round Up 4/22/19 | 04/25/19 |
| No summary available. | |
| Anixa Bio nabs a patent for CAR-T techno... | 04/17/19 |
| No summary available. | |
| Anixa Biosciences partners with Research... | 02/25/19 |
| No summary available. | |
| Anixa Biosciences extends collaboration ... | 02/21/19 |
| No summary available. | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Option Superstars | James Catzen | 75.00 % | Subscribe |
| Tracking ONLY-VOLBAND DAILY BREAK- | Jay | 53.00 % | Follow |
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.